Oral candidiasis secondary prevention: Difference between revisions
Jump to navigation
Jump to search
m (Changes made per Mahshid's request) |
(Category) |
||
Line 18: | Line 18: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Emergency mdicine]] | |||
[[Category:Disease]] | |||
[[Category:Primary care]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | |||
[[Category:Otolaryngology]] | |||
[[Category:Pediatrics]] | |||
[[Category:Immunology]] |
Revision as of 19:23, 21 September 2017
Oral candidiasis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Oral candidiasis secondary prevention On the Web |
American Roentgen Ray Society Images of Oral candidiasis secondary prevention |
Risk calculators and risk factors for Oral candidiasis secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Ahmed Younes M.B.B.CH [2]
Overview
Candida is usually a self limiting disease unless concurrent immunosuppression is present.
Secondary prevention
- Proper treatment of candididiasis using topical agents is usually enough for controlling symptoms.
- In immunocompromised patients, prophylactic fluconazole is effective in reducing recurrences.[1]
References
- ↑ Pappas PG, Kauffman CA, Andes D, Benjamin DK, Calandra TF, Edwards JE; et al. (2009). "Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America". Clin Infect Dis. 48 (5): 503–35. doi:10.1086/596757. PMID 19191635.